期刊文献+

活性氧对平滑肌细胞合成基质金属蛋白酶-1,3及其抑制物的影响 被引量:1

Regulation by reactive oxygen species of matrix metalloproteinase-1,3 and tissue inhibitor of matrix metalloproteinase-1 in smooth muscle cells
下载PDF
导出
摘要 目的 :探讨活性氧 (ROS)对血管平滑肌细胞合成基质金属蛋白酶 - 1,3(MMP - 1,3)和基质金属蛋白酶抑制物 - 1(TIMP - 1)的影响 ,从而推测其是否促进动脉粥样硬化斑块的破裂。方法 :体外培养胎儿主动脉平滑肌细胞 ,加入含 10 0 μmol/L黄嘌呤 ,5U/L黄嘌呤氧化酶的无血清培养液 ,孵育 2 4h ,收集细胞上清液。用Westernblot ting方法检测浓缩后的细胞上清液中MMP - 1,3和TIMP - 1的含量。结果 :黄嘌呤 /黄嘌呤氧化酶组细胞上清液中的MMP - 1含量明显少于正常对照组 ,并且转化成活性形式 ;MMP - 3的含量明显多于正常对照组 ,并且转化成活性形式 ;TIMP - 1的含量明显少于正常对照组。结论 :ROS对MMPs-TIMPs平衡的影响很复杂 ,可能对动脉粥样硬化斑块的破裂起一定作用。 AIM: To understand whether reactive oxygen species promote the rupture of atherosclerotic plaques by regulating the balance of matrix metalloproteinase-1,3 (MMP-1,3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in smooth muscle cells. METHODS: Aortic smooth muscle cells from 4-6months-healthy abortive fetuses were incubated for 24 hours with xanthine (100 μmol/L) and xanthine oxidase (5 U/L) in vitro . MMP-1,3 and TIMP-1 in the concentrated culture media were measured by Western blotting ( n =3 independent experiments). RESULTS: Incubation with xanthine/xanthine oxdiase decreased the amount of MMP-1 in the aortic smooth muscle cells (21.2%±5.5% of the control group),and pro-MMP-1 was activated completely. Reactive oxygen species (ROS) also activated pro-MMP-3,and increased the production of MMP-3 in the aortic smooth muscle cells. On the other hand,ROS inhibited the production of TIMP-1 in the aortic smooth muscle cells. CONCLUSION: It is complicated that ROS regulates the balance of MMPs and TIMPs. ROS may contribute to matrix degradation and the rupture in the atherosclerotic plaques.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2003年第11期1497-1500,共4页 Chinese Journal of Pathophysiology
关键词 基质金属蛋白酶-1 3 动脉粥样硬化斑块 平滑肌细胞 活性氧 冠心病 Matrix metalloproteinases Arteriosclerosis Muscle,smooth Reactive oxygen species
  • 相关文献

参考文献8

  • 1崔鸣,陈凤荣,宋清华,朱应葆.氧化型胆固醇下调血管平滑肌细胞金属蛋白酶组织抑制剂基因表达[J].中国病理生理杂志,2002,18(6):622-624. 被引量:1
  • 2Xu XP, Meisel SR, Ong JM, et al. Oxidized low- density lipoprotein regulates matrix metalloproteinase - 9 and its tissue inhibitor in human monroe- derived macrophages[J]. Circulation, 1999, 99(8) : 993 - 998.
  • 3Rajagopalan S, Meng XP, Ramasamy S, et al. Reactive oxygen species produced by macrophage- derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro.Implications for atherosclerotic plaque stability[ J ]. J Clin Invest, 1996, 98(11): 2572-2579.
  • 4Kerr ME, Bender CM, Monti EJ. An introduction to oxygen free radicals[J]. Heart Lung, 1996, 25(3): 200- 209.
  • 5Irani K. Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling[J]. Circ Res, 2000, 87(3) : 179 - 183.
  • 6Dimmeler S, Zeiher AM. Reactive oxygen species and vsscular cell apoptosis in response to angiotensin Ⅱ and proatherosclerotic factors[J]. Regul Pept, 2000, 90( 1 - 3) : 19 --25.
  • 7Kansch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature[J]. Circ Res, 1999, 85.(8) : 753 - 766.
  • 8Galis ZS, Asanuma K, Godin D, et al. N- acetyl- cysteine decreases the matrix - degrading capacity of macrophage- derived foam cells: new target for antioxidant therapy? [J]. Circulation, 1998, 97(24): 2445- 2453.

二级参考文献1

同被引文献23

  • 1车京津,黄体钢,周丽娟.CRP诱导单核细胞表达CD11b和CCR2并影响脂蛋白对CD11b和CCR2表达的观察[J].中华微生物学和免疫学杂志,2006,26(7):627-631. 被引量:2
  • 2Singh SK, Suresh MV, Voleti B, et al. The connection between C- reactive protein and atherosclerosis. The connection between C-reactive protein and atherosclerosis [J]. Ann Med, 2008, 40 (2): 110- 120.
  • 3Hanriot D, Bello G, Ropars A, et al. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes [J]. Thromb Haemost, 2008, 99 (3):558-569.
  • 4Kawahara K, Biswas KK, Unoshima M, et al. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells [J]. Cardiovasc Pathol, 2008, 17(3):129-138.
  • 5Devaraj S, Swarbrick MM, Singh U, et al. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers[J]. Am J Clin Pathol, 2008, 129(5):815-822.
  • 6Song CJ, Nakagomi A, Chandar S, et al. C-reactive protein contributes to the hypercoagulable state in coronary artery disease [J]. J Thromb Haemost, 2006, 4(1):98-106.
  • 7Lange LA, Carlson CS, Hindorff LA, et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events [J]. JAMA, 2006, 296(22):2703-2711.
  • 8Montecucco F, Mach F. New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor [J]. Clin Interv Aging, 2008, 3(2):341-349.
  • 9Ferri C, Croce G, Cofini V, et al. C-reactive protein: interaction with the vascular endothelium and possible role in human [J]. Atherosclerosis, 2007, 13(16):1631-1645.
  • 10Shakouri P, Nezami N, Tarzamni MK, et al. The elusive link between high sensitivity C-reactive protein and carotid subclinical atherosclerosis in coronary artery bypass grafting candidates: a cross-sectional study[J]. Cardiovasc Ultrasound, 2008, 6:23.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部